Frontiers P2RY12-Inhibitors Reduce Cancer-Associated Thrombosis and Tumor Growth in Pancreatic Cancers
Por um escritor misterioso
Descrição
Ana Luisa Palacios Acedo (@PalaciosAcedo) / X
paraneoplastic syndrome - List of Frontiers' open access articles
Frontiers Platelet-Cancer Interplay: Molecular Mechanisms and New Therapeutic Avenues
CAFs/tumor cells co-targeting DNA vaccine in combination with low-dose gemcitabine for the treatment of Panc02 murine pancreatic cancer: Molecular Therapy - Oncolytics
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial - The
Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia
paraneoplastic syndrome - List of Frontiers' open access articles
P2Y12 Receptor Modulates Sepsis-Induced Inflammation
18 Scientific articles published featuring Nanolive live cell imaging
Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment
P2Y12 Receptor Modulates Sepsis-Induced Inflammation
PDF) Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells
Inflammasomes in breast cancer: the ignition spark of progression and resistance?, Expert Reviews in Molecular Medicine
PDF) P2RY12-Inhibitors Reduce Cancer-Associated Thrombosis and Tumor Growth in Pancreatic Cancers
Human Colorectal Cancer Cell Line Ht29 (ATCC), Bioz
de
por adulto (o preço varia de acordo com o tamanho do grupo)